PB-22-d9 (exempt preparation) (Synonyms: QUPIC-d9) |
| Catalog No.GC48657 |
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
PB-22-d9 (exempt preparation) is intended for use as an internal standard for the quantification of PB-22 by GC- or LC-MS. PB-22 is categorized as a synthetic cannabinoid.1 It mimics the effects of δ9-THC . PB-22 is regulated as a Schedule I compound in the United States. PB-22-d9 (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
1.Banister, S.D., Stuart, J., Kevin, R.C., et al.Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135ACS Chem. Neurosci.6(8)1445-1458(2015)
Average Rating: 5 (Based on Reviews and 38 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *